Penehyclidine hydrochloride

DRUG2 trials

Sponsors

Peking University First Hospital, Sun Yat-sen University

Conditions

AnticholinergicsBimaxillar SurgeryHigh RiskInhalation Therapy; ComplicationsPenehyclidinePerioperative Respiratory Adverse EventsPostoperative Nausea and VomitingRespiratory Hypersensitivity

Phase 4

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

RecruitingNCT06624696

Sun Yat-sen UniversityAnticholinergics, High Risk, Inhalation Therapy; Complications +2

Start: 2024-11-12End: 2026-09-30Target: 204Updated: 2026-04-14

Unknown Phase

Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery

CompletedNCT04112771

Peking University First HospitalBimaxillar Surgery, Penehyclidine, Postoperative Nausea and Vomiting

Start: 2019-10-07End: 2019-12-30Updated: 2020-06-30

Related Papers

Inhaling penehyclidine to prevent perioperative respiratory adverse events in children at risk undergoing sevoflurane anesthesia (PEPSI trial): study protocol for a double-blind, randomized, placebo-controlled trial

Trials2026-04-02

Penehyclidine for prevention of postoperative nausea and vomiting following bimaxillary orthognathic surgery: a randomized, double-blind, controlled trial.

2021-11-0513 citations